Cerebrospinal folate levels in epileptics and their response to folate therapy.
D000927:Anticonvulsants / Q000009:adverse effects; D001812:Blood-Brain Barrier; D002986:Clinical Trials as Topic; D004827:Epilepsy / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D005492:Folic Acid / Q000009:adverse effects / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism* / Q000627:therapeutic use; D005494:Folic Acid Deficiency / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D010634:Phenobarbital / Q000378:metabolism; D010672:Phenytoin / Q000378:metabolism; D011324:Primidone / Q000378:metabolism; D012640:Seizures / Q000209:etiology; D013763:Tetrahydrofolates / Q000627:therapeutic use; D014805:Vitamin B 12 / Q000627:therapeutic use
D000927:Anticonvulsants; D013763:Tetrahydrofolates; D011324:Primidone; D010672:Phenytoin; D005492:Folic Acid; D014805:Vitamin B 12; D010634:Phenobarbital